Edition:
United States

Shanghai Pharmaceuticals Holding Co Ltd (601607.SS)

601607.SS on Shanghai Stock Exchange

19.49CNY
18 Sep 2018
Change (% chg)

¥0.13 (+0.67%)
Prev Close
¥19.36
Open
¥19.20
Day's High
¥19.66
Day's Low
¥19.07
Volume
12,030,433
Avg. Vol
10,585,553
52-wk High
¥27.29
52-wk Low
¥19.07

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- December 18 Sep 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 5 5 6 6
(2) OUTPERFORM 6 6 6 6
(3) HOLD 4 4 4 4
(4) UNDERPERFORM 1 0 0 0
(5) SELL 0 1 1 1
No Opinion 0 0 0 0
Mean Rating 2.06 2.12 2.06 2.06

Consensus Estimates Analysis

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Dec-18 16 159,541.00 184,646.00 139,561.00 156,573.00
Year Ending Dec-19 16 177,106.00 209,136.00 148,966.00 177,994.00
Earnings (per share)
Year Ending Dec-18 15 1.41 1.51 1.30 1.53
Year Ending Dec-19 15 1.60 1.75 1.50 1.74
LT Growth Rate (%) 1 12.75 12.75 12.75 12.89

Historical Surprises

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 35,428.10 36,386.10 957.98 2.70
Quarter Ending Dec-17 34,692.60 31,815.70 2,876.88 8.29
Quarter Ending Sep-17 32,018.40 33,252.60 1,234.14 3.85
Quarter Ending Jun-17 45,554.90 32,649.40 12,905.53 28.33
Quarter Ending Mar-17 31,947.40 33,129.50 1,182.13 3.70

Consensus Estimates Trend

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Dec-18 159,541.00 159,541.00 160,798.00 160,421.00 156,573.00
Year Ending Dec-19 177,106.00 177,106.00 179,030.00 178,712.00 177,994.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Dec-18 0 0 2 3
Year Ending Dec-19 0 0 2 3
Earnings